New combo therapy aims to halt liver tumors in patients with advanced neuroendocrine cancer
NCT ID NCT04339036
First seen Nov 01, 2025 · Last updated May 02, 2026 · Updated 19 times
Summary
This study tests whether adding a type of internal radiation (Yttrium-90) to a standard chemotherapy regimen (Capecitabine and Temozolomide) can better control neuroendocrine tumors that have spread to the liver and cannot be surgically removed. About 70 adults with grade 2 or 3 disease will receive the combination therapy. The goal is to see if this approach delays tumor growth in the liver more than either treatment alone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROENDOCRINE TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Roswell Park Comprehensive Cancer Center
RECRUITINGBuffalo, New York, 14203, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
UC San Diego
RECRUITINGLa Jolla, California, 92037, United States
Contact Email: •••••@•••••
Contact Email: •••••@•••••
Contact
-
University of Miami Miller School of Medicine-Sylvester Cancer Center
RECRUITINGMiami, Florida, 33136, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Pennsylvania
RECRUITINGPhiladelphia, Pennsylvania, 19103, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.